Skip to main content
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: Pediatr Nephrol. 2016 May 18;32(7):1109–1121. doi: 10.1007/s00467-016-3411-8

Table 3.

Drugs and Conditions which Increase Risk for Hyperkalemia
Diabetes mellitus
Advanced age
Beta-blockers
Nonsteroidal anti-inflammatory drugs
Angiotensin converting enzyme inhibitors
Angiotensin receptor blockers
Adrenal insufficiency, congenital adrenal hyperplasia
Aldosterone synthase deficiency or inhibitors (heparin, ketoconazole)
Loss-of-function mutations in the mineralocorticoid receptor or antagonists (spironolactone, eplerenone, drosperinone)
Loss-of-function mutations in the epithelial sodium channel or inhibitors (amiloride, triamterene, trimethoprim, pentamidine)
Decreased glomerular filtration rate